BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2122911)

  • 21. Immunomodulation by bacterial endotoxin.
    Burrell R
    Crit Rev Microbiol; 1990; 17(3):189-208. PubMed ID: 1689164
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.
    Mitov IG; Terziiski DG
    Infection; 1991; 19(6):383-90. PubMed ID: 1816107
    [No Abstract]   [Full Text] [Related]  

  • 23. Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).
    Imbach P; Hässig A; Cottier H
    Curr Stud Hematol Blood Transfus; 1992; (59):301-23. PubMed ID: 1572217
    [No Abstract]   [Full Text] [Related]  

  • 24. Bacterial lipopolysaccharide and its lipid A component: some historical and some current aspects.
    Westphal O; Lüderitz O; Rietschel ET; Galanos C
    Biochem Soc Trans; 1981 Jun; 9(3):191-5. PubMed ID: 7274542
    [No Abstract]   [Full Text] [Related]  

  • 25. Bacteraemic and endotoxic shock.
    Wardle N
    Br J Hosp Med; 1979 Jul; 22(1):104. PubMed ID: 476340
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins.
    Westphal O; Jann K; Himmelspach K
    Prog Allergy; 1983; 33():9-39. PubMed ID: 6187018
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].
    Rietschel ET; Brade H
    Infection; 1987; 15(2):133-41. PubMed ID: 2439461
    [No Abstract]   [Full Text] [Related]  

  • 28. Endotoxin in septic shock.
    Hoffman WD; Natanson C
    Anesth Analg; 1993 Sep; 77(3):613-24. PubMed ID: 8368563
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal.
    Baumgartner JD
    Infect Dis Clin North Am; 1991 Dec; 5(4):915-27. PubMed ID: 1723740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies.
    Barclay GR; Scott BB
    Infect Immun; 1987 Nov; 55(11):2706-14. PubMed ID: 3312008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic value of serum levels of antibacterial and anti-lipid A antibodies in renal infections].
    Mastrolitti G; Jirillo E; Pace G; Montagna MT; Selvaggi FP; Fumarola D; Schena FP
    Minerva Nefrol; 1981; 28(1):63-6. PubMed ID: 7290511
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 33. [Monoclonal antibodies in the treatment of sepsis and septic shock].
    Torrabadella de Reynoso P; Salgado Remigio A; Peracaula Picart R
    Med Clin (Barc); 1992 Dec; 99(20):784-92. PubMed ID: 1460952
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of septic shock with immunotherapy.
    Smith AL
    Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of common polysaccharide antigen of Pseudomonas aeruginosa with O-antiserum to Pseudomonas cerasi.
    Kocharova NA; Knirel YA; Romanowska A; Romanowska E; Makarenko TA; Edvabnaya LS; Stanislavsky ES; Zdorovenko GM; Yakovleva LM
    FEMS Microbiol Immunol; 1991 Apr; 3(2):69-73. PubMed ID: 1713775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis.
    Dunn DL; Bogard WC; Cerra FB
    Surgery; 1985 Aug; 98(2):283-90. PubMed ID: 3895540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunogenic and antigenic properties of bacterial cells, lipopolysaccharides and lipids A of Aeromonas sobria and non 01 vibrio cholerae].
    Kuźniewski P
    Med Dosw Mikrobiol; 1988; 40(2):91-7. PubMed ID: 3216766
    [No Abstract]   [Full Text] [Related]  

  • 38. Diverse VH and V kappa genes encode antibodies to Pseudomonas aeruginosa LPS.
    Emara MG; Tout NL; Kaushik A; Lam JS
    J Immunol; 1995 Oct; 155(8):3912-21. PubMed ID: 7561098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of antibodies against bacterial lipopolysaccharides and lipid A by immunoblotting.
    Fink PC; Bokelmann G; Haeckel R
    Prog Clin Biol Res; 1989; 308():1043-51. PubMed ID: 2780685
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies to lipopolysaccharide.
    Poxton IR
    J Immunol Methods; 1995 Oct; 186(1):1-15. PubMed ID: 7561138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.